§ BIOTECHNOLOGY
USD · BiotechnologyPVLA
PALVELLA THERAPEUTICS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
129 increased/new, 46 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 1.2M | 3.7% | +29% |
| First Light Asset Management, LLC | 981K | 11.0% | +38% |
| BVF INC/IL | 961K | 3.8% | +9% |
| Frazier Life Sciences Management, L.P. | 882K | 2.8% | +22% |
| BlackRock, Inc. | 687K | 0.0% | +23% |
| JENNISON ASSOCIATES LLC | 641K | 0.1% | +65% |
◇ AC INTELLIGENCE
Top institutional owners for PVLA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER77.8% · 125 holders
QUALITY / COMPOUNDER17.8% · 18 holders
DEALER / BANK8.7% · 19 holders
PASSIVE / INDEX7.8% · 7 holders
TACTICAL / MACRO2.0% · 4 holders
INCOME / DEFENSIVE0.8% · 8 holders
SYSTEMATIC / QUANT0.2% · 2 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for PVLA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention PVLA yet.